Antimicrobial susceptibilities and serogroups of clinical strains of Clostridium difficile isolated in France in 1991 and 1997. (Q30804635)

12 September 2017

Antimicrobial susceptibilities and serogroups of clinical strains of Clostridium difficile isolated in France in 1991 and 1997. (English)

1 reference

12 September 2017

Clostridium difficile

0 references

author name string

F Barbut

1 reference

12 September 2017

D Decré

1 reference

12 September 2017

B Burghoffer

1 reference

12 September 2017

D Lesage

1 reference

12 September 2017

F Delisle

1 reference

12 September 2017

V Lalande

1 reference

12 September 2017

M Delmée

1 reference

12 September 2017

V Avesani

1 reference

12 September 2017

N Sano

1 reference

12 September 2017

C Coudert

1 reference

12 September 2017

J C Petit

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

Antimicrobial Agents and Chemotherapy

12 September 2017

1 reference

12 September 2017

1 reference

12 September 2017

1 reference

12 September 2017

2607-2611

1 reference

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

Clostridium difficile-Associated Diarrhea in HIV-Infected Patients: Epidemiology and Risk Factors

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

Use of an enzyme-linked immunoassay for Clostridium difficile serogrouping

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

Clostridium difficile colonization and diarrhea at a tertiary care hospital

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

Clostridium difficile colitis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

In vitro susceptibility of Clostridium difficile isolates from patients with antibiotic-associated diarrhea or colitis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

Clostridium difficile and its cytotoxin in feces of patients with antimicrobial agent-associated diarrhea and miscellaneous conditions.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

Antimicrobial susceptibility of Clostridium difficile determined by disc diffusion and breakpoint methods.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

Correlation between serogroup and susceptibility to chloramphenicol, clindamycin, erythromycin, rifampicin and tetracycline among 308 isolates of Clostridium difficile

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

Nosocomial acquisition of Clostridium difficile infection

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

Evaluation of the E test for susceptibility testing of anaerobic bacteria

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

In vitro activities of ramoplanin and four glycopeptide antibiotics against clinical isolates of Clostridium difficile

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

In-vitro activity of vancomycin, teicoplanin, daptomycin, ramoplanin, MDL 62873 and other agents against staphylococi, enterococci and Clostridium difficile

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

Prospective study of oral teicoplanin versus oral vancomycin for therapy of pseudomembranous colitis and Clostridium difficile-associated diarrhea

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

Antimicrobial susceptibility of Clostridium difficile strains isolated from hospitalised patients with acute diarrhoea

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

Antibiotic-Associated Pseudomembranous Colitis Due to Toxin-Producing Clostridia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

Antimicrobial Susceptibilities of Equine Isolates ofClostridium difficileand Molecular Characterization of Metronidazole‐Resistant Strains

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

Susceptibility testing of anaerobes with Etest.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

Management and control of a large outbreak of diarrhoea due to Clostridium difficile

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89532

Comparison of the E test and a reference agar dilution method for susceptibility testing of anaerobic bacteria

25 November 2018

1 reference

12 December 2020

Investigation of a nosocomial outbreak of Clostridium difficile-associated diarrhoea among AIDS patients by random amplified polymorphic DNA (RAPD) assay

1 reference

12 December 2020

Diarrhoea caused by Clostridium difficile: response time for treatment with metronidazole and vancomycin

1 reference

12 December 2020

Prevalence and pathogenicity of Clostridium difficile in hospitalized patients. A French multicenter study

1 reference

12 December 2020

Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations

1 reference

12 December 2020

Susceptibility of Clostridium difficile strains to new antibiotics: quinolones, efrotomycin, teicoplanin and imipenem

1 reference

12 December 2020

Epidemiology and prevention of Clostridium difficile infections in a leukemia unit

1 reference

12 December 2020

In vitro activity of quinolones and other antimicrobial agents against anaerobic bacteria

1 reference

12 December 2020

Identifiers

1 reference

12 September 2017

PubMed publication ID

10543736

1 reference